EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity | Zendy

Brockow Knut | Zendy; ArdernJones Michael R. | Zendy; Mockenhaupt Maja | Zendy; Aberer Werner | Zendy; Barbaud Annick | Zendy; Caubet JeanChristoph | Zendy; Spiewak Radoslaw | Zendy; Torres María José | Zendy; Mortz Charlotte G. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Author(s) -

Brockow Knut,

ArdernJones Michael R.,

Mockenhaupt Maja,

Aberer Werner,

Barbaud Annick,

Caubet JeanChristoph,

Spiewak Radoslaw,

Torres María José,

Mortz Charlotte G.

Publication year - 2019

Publication title -

allergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.363

H-Index - 173

eISSN - 1398-9995

pISSN - 0105-4538

DOI - 10.1111/all.13562

Subject(s) - medicine , dermatology , position paper , drug , drug allergy , position (finance) , pharmacology , pathology , finance , economics

Drug hypersensitivity reactions ( DHR s) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHR s ( CDHR ) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research